Featured Articles

  MRI   Translational Research for Interventional Magnetic Resonance Imaging and Magnetic Resonance Visualisation of Vascular Implants
Andreas Melzer Director, Institute for Medical Science and Technology, Universities of Dundee and St Andrews
The new Dundee Clinical Research Centre (CRC) is a joint activity of the College of Medicine and NHS Tayside Ninewells Hospital and Medical School – one of the largest teaching hospitals in Europe.
 
         
  signal  

Safety Aspects in Carotid Artery Stenting - Is Flow Reversal the Solution?
Johan Formgren Head of Peripheral Vascular Interventions, Department of Medical Imaging, Södersjukhuset AB, Stockholm
Since the publication of the Endarterectomy versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) and Stent-supported Percutaneous Angioplasty of the Carotid Artery versus Endarterectomy (SPACE) studies, doubts have been raised regarding the safety of CAS as an alternative carotid intervention to CEA.

 
         
  Skylor stent
  LEONARDO - Clinical Evaluation of a Last Generation Coronary Stent in a Real World Typical Non-DES Population - A Prospective, Single-centre Registry
Jacques J Koolen and Maria Rosaria De Vita, Catharina Hospital, The Netherlands and Policlinico Gemelli Universita Cattolica Sacro Cuore, Italy
While rates of restenosis and MACEs have both been demonstrated to be significantly reduced with the use of drugeluting stents (DES) compared with BMS in a broad variety of trials,1–6 the same trials could not demonstrate any difference in mortality or AMI rates.
 


Issues in Cardiac Resynchronization Treatment
Cardiology
The Society for Cardiac Angiography and Interventions American Heart Association  Heart Online    Association of British Medical Journals   TCTMD
Cardiology » Articles » Issues in Cardiac Resynchronization Treatment
Wednesday, 23 July, 2008



Issues in Cardiac Resynchronization Treatment

Tasneem Z Naqvi Director, Echocardiography Service, University of Southern California

  Previous     1   2    3     Next  

Myocardial Viability

Presence of myocardial viability is another important predictor of response to CRT and has not been well evaluated. Limited studies have shown that detection of a significant amount of myocardial scar despite the presence of mechanical asynchrony predicts lack of response to cardiac resynchronization.23

Pacemaker Programming

Atrioventricular and Interventricular Delays

Another important parameter that is often overlooked is whether or not the biventricular pacemaker is appropriately programmed.24 Optimal atrioventricular (AV) delay was determined by earlier studies from diastolic filling time of mitral inflow. Nominal settings for pacemaker devices include typically short AV delays of 100–120ms. These data come from good biventricular capture at short AV delays, and also show that echo-derived diastolic mitral inflow filling time is the longest at short AV delays. However, short AV delays often lead to premature mitral valve closure. This reduces forward atrial contribution in late diastole and leads to pulmonary vein atrial flow reversal and, in turn, increased pulmonary venous pressure. Thus, longest diastolic mitral inflow filling time is not necessarily associated with best cardiac output. In the author’s experience, patients have needed AV delays between 30ms and 290ms. Therefore, programming of AV delay needs to be performed on an individual basis.

Despite the availability of interventricular or sequential ventricular programming capability, the devices are often left in simultaneous pacing mode following implantation. While studies have shown that the majority of patients need LV pre-excitation for better cardiac output, at least one-third of patients have better hemodynamics with simultaneous LV and right ventricular (RV) pacing or even RV pre-excitation.25 Unless tested, optimal interventricular timing in a patient cannot be predicted based on ECG.

Atrial Pacing versus Sensing

Some patients who might be better off with atrial sensing are often inappropriately atrially paced at relatively higher heart rates such as 70bpm. Programming a lower back-up atrial pacing rate down to, for example, 50bpm often allows intrinsic atrial rhythm and heart rate variability during exercise.

Pacemaker Response to Exercise

Although advantage is often taken of the capability of current generation pacemakers to increase heart rate in response to exercise in chronotropically incompetent patients, it is not uncommon that patients continue to have markedly limited heart rate variability and hence get symptomatic after minimal exercise. Except in truly sedentary patients, this often results from lack of device sensitivity to detect mechanical activity. In some patients referred for optimization who are chronotropically incompetent or atrially paced, exercise-induced increase in heart rate function is turned ‘off.’ Sometimes slope of activation timing depending on lower rate limit may delay increase in heart rate upon commencement of exercise and hence results in inappropriate early quitting of exercise. Simple adjustment of pacemaker sensitivity and/or slope may overcome this problem. Change in the exercise-induced change in AV delay is another area where little investigation has been carried out. Currently, all devices allow decrease in AV delay with increases in heart rate, however the magnitude of AV delay change for a given increase in heart rate is too little, hence the pacemaker algorithm of AV shortening in the current generation pacemakers may not be appropriate for all patients.

Sleep Apnea

Another ignored factor that leads to lack of response to CRT or worsening of symptoms after initial response is the presence of sleep apnea in a significant number of CHF patients post-CRT. It is known that sleep apnea leads to worsening of heart failure. Our evaluation has suggested potential mechanisms of worsening of heart failure symptoms with sleep apnea. These include marked tachycardia compromising diastolic filling, worsening of mitral regurgitation and exaggerated ventricular interdependence during the hyperpneic phase of the sleep apnea cycle,26 and ventricular ectopy during the bradypneac phase.



Experience at the Author’s Institution

At the author’s center, potential patients for CRT are evaluated for the presence of mechanical dyssynchrony irrespective of presence of electrical asynchrony by means of tissue Doppler imaging echocardiography and twodimensional strain imaging by speckle tracking. All published criteria that have evaluated mechanical dyssynchrony are used. There is often a lack of concordance between different parameters in the majority of patients except those with the most severe mechanical dyssynchrony. An algorithm has therefore been developed to report dyssynchrony based on the author’s experience in evaluating over 600 tissue Doppler studies (see Table 1). Mechanical dyssynchrony is reported as present if there are three major, two major and two intermediate; one major and three intermediate; four intermediate, two intermediate and two minor; or one intermediate and three minor positive criteria.

  Previous     1   2    3     Next  

Keywords and Categories
Category:



Author(s) Biography
Tasneem Z Naqvi, MD, is Director of Echocardiography Services at the University of Southern California and Professor of Clinical Medicine at Keck School of Medicine in Los Angeles, California. Dr Naqvi is a cardiologist and researcher specializing in the performance and interpretations of transthoracic echo-Doppler studies, transesophageal echo-Doppler studies, and vascular ultrasound studies, as well as stress echocardiographic studies. Dr Naqvi is a member of many professional societies, including the Society of Vascular Medicine and Biology Writing Group, and the Vascular Strategy Task Force. She is a reviewer for several journals, an editorial board member for the Journal of American Society of Cardiology and Minerva Cardioangiologica, and the imaging section editor for Cardiology Review. Dr Naqvi is board-certified in the American Board of Internal Medicine and the American Board of Cardiovascular Disease, and holds Comprehensive Certification in Adult Echocardiography from the National Board of Echocardiography. She is a Certified Vascular Technologist and a Fellow of the American College of Cardiology. She is also a Fellow of the Royal College of Physicians. While in the UK, she became Senior House Officer in Internal Medicine at Lister Hospital, Stevenage and became Registrar in Internal Medicine at Queen Elizabeth University Hospital, Birmingham. She then continued her residency in Internal Medicine in the US at Stony Brook University Hospital in New York and her fellowship in clinical cardiology at Cedars-Sinai Medical Center in Los Angeles, California. E: tasneem.naqvi@cshs.org

Send Article Feedback
Title*:

Comment*:

Name*:
Email Address*:
Location*:

Add me to mailing list

I Agree to terms and conditions


Order Reprint


Order high-quality repints of any
articles on this website


Instructions for Authors
Instructions for authors, click here for details

Submit an Article
Submit an article, click here for details

  Copyright Touch Briefings 2005 - 2008    Promotional Opportunities | Terms & Conditions | Privacy Statement|

Articles : a b c d e f g h i j k l m n o p q r s t u v w x y z
Companies : a b c d e f g h i j k l m n o p q r s t u v w x y z
Events : a b c d e f g h i j k l m n o p q r s t u v w x y z
Keywords : a b c d e f g h i j k l m n o p q r s t u v w x y z

Specialities :

Arrhythmia Cardiac Imaging Congenital Heart Disease Coronary Artery Disease Heart Disease Prevention Heart Failure Hyperlipidemia Hypertension Interventional Cardiology Pediatric Cardiology Peripheral Artery Disease

Other Touch Group sites:   

Neurology - Endocrine Disease - Oncological Disease - Gastroenterology - Respiratory Disease